A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1
Richard Crook(Mayo Clinic in Florida), Matti Haltia(University of Helsinki), John Hardy(National Hospital for Neurology and Neurosurgery), Minna Pöyhönen(Väestöliitto), Nitin D. Mehta(Jacksonville College), Mirja Somer(Väestöliitto), Matthew J. Farrer(University of Florida), Matt Baker(Jacksonville College), Hannu Kalimo(University of Turku), Jordi Pérez‐Tur(University of South Florida), Katrina Gwinn(Mayo Clinic in Arizona), Raija Ylikoski(Helsinki University Hospital), Henry Houlden(National Hospital for Neurology and Neurosurgery), Sarah Lincoln(Jacksonville College), Mike Hutton(Salisbury District Hospital), Auli Verkkoniemi(Helsinki University Hospital), Steve Kucera(University of Tampa), Anders Paetau(Helsinki University Hospital)
Cited by 349
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
|Nature|2006|2.1k